Immunosuppressive molecules such as IDO, PGE2, TGF-β, prostaglandins, and IL-10 from the tumor microenvironment inhibit NK cell activity and downregulate activating receptors [81,82,83,84,85]. The gene discussed is TGFB1; the disease is neoplasm.